Pfizer

Sep 24, 2021

In Brief This Week: PerkinElmer, Chembio, Becton Dickinson, Fulgent Genetics, and More

Mar 4, 2021

FDA Expands Approval of Pfizer's Lorbrena to First-Line ALK-Positive NSCLC; Approves Roche CDx

Oct 30, 2020

Opko Health Q3 Revenues Up 87 Percent

Oct 29, 2020

Roche EGFR Mutation Test Approved by FDA as Companion Diagnostic for NSCLC

Oct 8, 2020

In Brief This Week: Exact Sciences, Danaher, Yourgene Health

Feb 24, 2020

Pilot Program Aims for Routine Screening of Duchenne Muscular Dystrophy
Premium

Sep 23, 2019

Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines
Premium

Apr 30, 2019

Exact Sciences Q1 Revenues Up 79 Percent

Jan 16, 2019

Qiagen EGFR Assay Approved in Japan as CDx to Pfizer NSCLC Drug

Oct 30, 2018

Exact Sciences Q3 Revenues Up 63 Percent

Oct 16, 2018

FDA Approves Myriad Genetics BRCA CDx With Pfizer's Metastatic Breast Cancer Drug

Oct 12, 2018

AmoyDx Lung Cancer CDx Approved in South Korea

Oct 10, 2018

Myriad Upgraded to Overweight by Piper Jaffray; Signs Lab Service Deal with Pfizer

Aug 22, 2018

Exact Sciences, Pfizer to Comarket Cologuard

Jun 18, 2018

Myriad Genetics Submits Supplementary PMA for BRACAnalysis CDx

May 21, 2018

Pfizer to Offer $1.5M in Grant Funding to Support BRCA Testing

Apr 11, 2018

Pfizer, Oxford BioDynamics, U of Glasgow Researchers Develop Approach to Gauge Response to RA Drug
Premium

Feb 6, 2018

Quest to Offer Thermo Fisher's Oncomine Dx Target Test

Jan 30, 2018

NIH Launches Parkinson's Disease Research Partnership

Jan 16, 2018

Pfizer, Foundation Medicine Developing Companion Diagnostics for Cancer Drugs